United States · FDA National Drug Code directory
Bepotastine Besilate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0378-7055_c8ce95fa-e800-433e-8d40-70a6b1e06140
- Product NDC
- 0378-7055
- Form
- SOLUTION/ DROPS
- Composition / generic term
- Bepotastine Besilate
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210528
- Source listing expiry
- 20261231
Source-listed ingredients
- BEPOTASTINE BESILATE — 15 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (0378-7055-35) / 5 mL in 1 BOTTLE, DROPPER · 0378-7055-35
- 1 BOTTLE, DROPPER in 1 CARTON (0378-7055-67) / 10 mL in 1 BOTTLE, DROPPER · 0378-7055-67
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →